Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Co…
Industry Peers
Medical Instruments & Supplies| Headline | Source | Time |
|---|---|---|
Yesterday | ||
This week | ||
Coloplast AS (CLPBF) (Q3 2026) Earnings Call Highlights: Organic Growth Steady at 6% Amid US ... Coloplast AS (CLPBF) delivers 6% organic revenue growth and 5% EBIT growth in constant currencies, while navigating US reimbursement headwinds and China inventory adjustments. | ||
Older | ||
Gieves & Hawkes’s Savile Row home sold to Danish catheter tycoon The Savile Row home of luxury menswear tailor Gieves & Hawkes has been snapped up for £31m by a Danish catheter billionaire. | ||
3 European Stocks Possibly Trading At Discounts Of Up To 39.2% The European stock market has experienced a mixed performance recently, with the pan-European STOXX Europe 600 Index showing modest gains amid easing geopolitical tensions and strong corporate earnings. However, concerns over potential U.S. tariffs on EU goods have introduced some volatility into the market landscape. In such an environment, identifying stocks that are potentially undervalued can be crucial for investors looking to capitalize on discrepancies between a company's intrinsic... | ||
Uncovering 3 European Stocks That May Be Priced Below Intrinsic Value Estimates As the pan-European STOXX Europe 600 Index concluded a turbulent week with modest gains, investor sentiment was buoyed by easing geopolitical tensions and robust corporate earnings across the region. However, concerns over potential U.S. tariffs on EU goods introduced some volatility into the markets. In this environment, identifying stocks that may be priced below their intrinsic value estimates can offer opportunities for investors seeking to capitalize on market inefficiencies and strong... | ||
Coloplast AS (CLPBF) Q2 2026 Earnings Call Highlights: Strong Organic Growth Amidst Market ... Coloplast AS (CLPBF) reports robust growth in key segments despite facing pressures from inflation and market competition. | ||
European Market: Nokian Renkaat Oyj And Two Other Stocks That May Be Priced Below Estimated Value In recent weeks, the European market has experienced modest gains amid easing geopolitical tensions and strong corporate earnings, although concerns over potential U.S. tariffs on EU goods have weighed on investor sentiment. As the European Central Bank signals potential rate hikes to combat rising inflation, investors are increasingly focused on identifying stocks that may be undervalued relative to their intrinsic value amidst these complex economic conditions. | ||
European Stocks Estimated To Be Up To 30.8% Below Their Intrinsic Value The European stock market recently experienced a volatile week, with modest gains in the pan-European STOXX Europe 600 Index, as investor sentiment was buoyed by easing geopolitical tensions and strong corporate earnings. However, looming threats of increased tariffs from the U.S. added pressure to markets. In this context, identifying undervalued stocks becomes crucial for investors seeking opportunities that are potentially trading below their intrinsic value amidst fluctuating market... | ||
3 European Stocks Estimated To Be Trading Below Fair Value By As Much As 42.1% As European markets navigate a landscape marked by stalled geopolitical negotiations and fluctuating oil prices, the pan-European STOXX Europe 600 Index remains relatively stable, with corporate earnings showing positive momentum. Amid these conditions, identifying undervalued stocks becomes crucial for investors seeking opportunities that may offer potential value in a market where economic sentiment has dipped to its lowest since 2020. | ||
European Stocks Possibly Trading Below Estimated Value May 2026 As the European market navigates through a landscape marked by stable interest rates and geopolitical uncertainties, the pan-European STOXX Europe 600 Index has managed to maintain a steady course, reflecting cautious optimism amid positive earnings momentum. In this environment, identifying potentially undervalued stocks becomes crucial for investors seeking opportunities that may offer value relative to their estimated worth. | ||
Coloplast And 2 Other European Stocks That Might Be Priced Below Their Estimated Value As the pan-European STOXX Europe 600 Index ended the week broadly flat amid stalled geopolitical negotiations and fluctuating oil prices, investors are keenly observing potential opportunities in undervalued stocks. In this context, identifying stocks that might be priced below their estimated value can be crucial for those looking to capitalize on positive earnings momentum despite broader economic uncertainties. | ||